HPE Composable Infrastructure Platform Future-proofs IT at Netherlands Cancer Institute

This paper explains how HPE Synergy composable infrastructure platform and HPE ProLiant DL380 Gen10 cluster enabled the Netherlands Cancer Institute to accelerate research to advance discoveries of new cancer treatments and enhance efficiency.

Vendor:

Hewlett Packard Enterprise

Posted:

Apr 18, 2022

Published:

Apr 18, 2022

Format:

PDF

Type:

White Paper